Sustained release of herbal drugs using biodegradable scaffold for faster wound healing and better patient compliance

2018 ◽  
Vol 14 (7) ◽  
pp. 2131-2141 ◽  
Author(s):  
Arpan Biswas ◽  
Manori Amarajeewa ◽  
Sudipta Senapati ◽  
Manoranjan Sahu ◽  
Pralay Maiti
2020 ◽  
Vol 91 ◽  
pp. 106827
Author(s):  
Maryam Najafiasl ◽  
Shahriar Osfouri ◽  
Reza Azin ◽  
Sasan Zaeri

2021 ◽  
Vol 22 (12) ◽  
pp. 6267
Author(s):  
Meng-Jin Lin ◽  
Mei-Chun Lu ◽  
Hwan-You Chang

The goals of this study are to develop a high purity patented silk fibroin (SF) film and test its suitability to be used as a slow-release delivery for insulin-like growth factor-1 (IGF-1). The release rate of the SF film delivering IGF-1 followed zero-order kinetics as determined via the Ritger and Peppas equation. The release rate constant was identified as 0.11, 0.23, and 0.09% h−1 at 37 °C for SF films loaded with 0.65, 6.5, and 65 pmol IGF-1, respectively. More importantly, the IGF-1 activity was preserved for more than 30 days when complexed with the SF film. We show that the IGF-1-loaded SF films significantly accelerated wound healing in vitro (BALB/3T3) and in vivo (diabetic mice), compared with wounds treated with free IGF-1 and an IGF-1-loaded hydrocolloid dressing. This was evidenced by a six-fold increase in the granulation tissue area in the IGF-1-loaded SF film treatment group compared to that of the PBS control group. Western blotting analysis also demonstrated that IGF-1 receptor (IGF1R) phosphorylation in diabetic wounds increased more significantly in the IGF-1-loaded SF films group than in other experimental groups. Our results suggest that IGF-1 sustained release from SF films promotes wound healing through continuously activating the IGF1R pathway, leading to the enhancement of both wound re-epithelialization and granulation tissue formation in diabetic mice. Collectively, these data indicate that SF films have considerable potential to be used as a wound dressing material for long-term IGF-1 delivery for diabetic wound therapy.


2021 ◽  
Author(s):  
Xingyu Chen ◽  
Zuxin Wang ◽  
Shan Gao ◽  
Wanlin Zhang ◽  
Hanwen Gong ◽  
...  

The Tibetan eighteen flavor dangshen pills (TEP) are composed of 18 traditional Tibetan medicines, which are commonly used in the treatment of skin diseases in the Tibetan medicine system. They...


2020 ◽  
Vol 8 (20) ◽  
pp. 5647-5655
Author(s):  
Jifang Yuan ◽  
Qian Hou ◽  
Lingzhi Zhong ◽  
Xin Dai ◽  
Qiang Lu ◽  
...  

Inhibitor released slowly from silk-chitosan bionic scaffolds, resulting in the accelerated wound healing and hair follicle regeneration.


2019 ◽  
Vol 107 (7) ◽  
pp. 1414-1424 ◽  
Author(s):  
Jinfei Hou ◽  
Lifeng Chen ◽  
Zhirong Liu ◽  
Jialun Li ◽  
Jie Yang ◽  
...  

Pharmaceutics ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 447 ◽  
Author(s):  
Fabian Ávila-Salas ◽  
Adolfo Marican ◽  
Soledad Pinochet ◽  
Gustavo Carreño ◽  
Oscar Valdés ◽  
...  

This research proposes the rational modeling, synthesis and evaluation of film dressing hydrogels based on polyvinyl alcohol crosslinked with 20 different kinds of dicarboxylic acids. These formulations would allow the sustained release of simultaneous bioactive compounds including allantoin, resveratrol, dexpanthenol and caffeic acid as a multi-target therapy in wound healing. Interaction energy calculations and molecular dynamics simulation studies allowed evaluating the intermolecular affinity of the above bioactive compounds by hydrogels crosslinked with the different dicarboxylic acids. According to the computational results, the hydrogels crosslinked with succinic, aspartic, maleic and malic acids were selected as the best candidates to be synthesized and evaluated experimentally. These four crosslinked hydrogels were prepared and characterized by FTIR, mechanical properties, SEM and equilibrium swelling ratio. The sustained release of the bioactive compounds from the film dressing was investigated in vitro and in vivo. The in vitro results indicate a good release profile for all four analyzed bioactive compounds. More importantly, in vivo experiments suggest that prepared formulations could considerably accelerate the healing rate of artificial wounds in rats. The histological studies show that these formulations help to successfully reconstruct and thicken epidermis during 14 days of wound healing. Moreover, the four film dressings developed and exhibited excellent biocompatibility. In conclusion, the novel film dressings based on hydrogels rationally designed with combinatorial and sustained release therapy could have significant promise as dressing materials for skin wound healing.


:Increasing research interest has been focused on controlled as well as sustained drug delivery using natural and biocompatible constituents in recent years. Many of them herbal constituents are avoided due to pharmacokinetic and pharmacodynamic issues of herbal constituents. There are many new technological ways and comparisons have been studied to upgrade the herbal discoveries in pharmaceutical market. This review will focus on the nanogel for herbal medicines with high delivery rate, patient compliance and efficiency. A nanoparticles contained hydrogel with cross linked polymer networks called as ‘Nanogel’. Nanogel preferred for herbal medicines due to stability and for the ease. Nanogels in terms of herbal drugs are promising and novel approach which also can be called as future generation drug delivery systems owing to high drug encapsulation capacity, uniformity, minimum toxicity, greater stability.


Author(s):  
AHMED M AGIBA ◽  
WAGEEH ABDEL HAKEEM ◽  
ASHRAF G ZAYED

Objective: Ranolazine (RZ), antianginal drug indicated for the treatment of chronic stable angina pectoris, was formulated into sustained-release matrix tablets and optimized to improve patient compliance and achieve controlled release over a certain period. Methods: Different formulations were prepared by wet- and melt-granulation techniques. Excipients at different ratios as Eudragit® L100-55, Methocel™ E5, Avicel® PH-101, and carnauba wax powder were used to develop a ternary polymeric matrix system for the controlled delivery of RZ. The prepared formulations were subjected to granulometric and characteristic studies. Comparative dissolution and release kinetic studies of the selected formulation and the reference product, Ranexa® extended-release film-coated tablets, Gilead Sciences, Inc., USA, were further carried out to ensure product similarity. Results: The optimum pH-dependent to pH-independent polymers ratio was 1:1.3 (w/w). Extragranular carnauba wax in a concentration of 32.50 mg/tablet (2.50 gm% w/w) was the key excipient in controlling drug release kinetics by forming waxy matrix granules which prevent rapid dissolution. Modulation of the microenvironmental pH using a potent alkalinizing agent was very effective for controlling drug release patterns in different dissolution media from pH 1.2–6.8. Conclusion: The release of RZ from the matrix tablets was controlled for a period of 24 h, and thereby expected to provide patient compliance with minimal side effects.


Sign in / Sign up

Export Citation Format

Share Document